Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers

Autor: Caroline Holm Nørgaard, Sarah Friedrich, Charlotte Thim Hansen, Thomas Gerds, Clive Ballard, Daniel Vega Møller, Lotte Bjerre Knudsen, Kajsa Kvist, Bernard Zinman, Ellen Holm, Christian Torp‐Pedersen, Lina Steinrud Mørch

Publikováno v: Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 8, Iss 1, Pp n/a-n/a (2022)

Abstract Introduction People with type 2 diabetes have increased risk of dementia. Glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are among the promising therapies for repurposing as a treatment for Alzheimer's disease; a key unanswere

Externí odkaz: https://doaj.org/article/a3a27f9ddbfd4e1cafdac0c2aea95168

Investigating changes in fluid biomarkers in early Alzheimer’s disease: design of plasma biomarker analyses and a cerebrospinal fluid sub‐study in the evoke and evoke+ trials of semaglutide versus placebo

Autor: Jeffrey Cummings, Henrik Zetterberg, Alireza Atri, Charlotte Thim Hansen, Julie Broe Honore, Peter Johannsen, Filip Krag Knop, Lars Lau Raket, Mary Sano, Hilkka Soininen, Howard H. Feldman

Publikováno v: Alzheimer's & Dementia. 18

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b60ef1e9b463fc7b59b5b758aa6e54ad
https://doi.org/10.1002/alz.062382

Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers

Autor: Caroline Holm Nørgaard, Sarah Friedrich, Charlotte Thim Hansen, Thomas Gerds, Clive Ballard, Daniel Vega Møller, Lotte Bjerre Knudsen, Kajsa Kvist, Bernard Zinman, Ellen Holm, Christian Torp‐Pedersen, Lina Steinrud Mørch

Publikováno v: Norgaard, C H, Friedrich, S, Hansen, C T, Gerds, T, Ballard, C, Moller, D V, Knudsen, L B, Kvist, K, Zinman, B, Holm, E, Torp-Pedersen, C & Morch, L S 2022, ' Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia : Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers ', Alzheimers & dementia-Translational research & clinical interventions, vol. 8, no. 1, 12268 . https://doi.org/10.1002/trc2.12268
Nørgaard, C H, Friedrich, S, Hansen, C T, Gerds, T, Ballard, C, Møller, D V, Knudsen, L B, Kvist, K, Zinman, B, Holm, E, Torp-Pedersen, C & Mørch, L S 2022, ' Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia : Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers ', Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI), vol. 8, no. 1, e12268 . https://doi.org/10.1002/trc2.12268

IntroductionPeople with type 2 diabetes have increased risk of dementia. Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are among the promising therapies for repurposing as a treatment for Alzheimer's disease; a key unanswered question is wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f820cfefe48bc2aa8b8ef05a600463b0
https://pubmed.ncbi.nlm.nih.gov/35229024

Risk factors for chronic pain after hysterectomy: A nationwide questionnaire and database stud

Autor: Birgitte Brandsborg, Lone Nikolajsen, Charlotte Thim Hansen, Henrik Kehlet, Troels Staehelin Jensen

Publikováno v: Aarhus University
Brandsborg, B, Nikolajsen, L, Hansen, C T, Kehlet, H & Jensen, T S 2007, ' Risk factors for chronic pain after hysterectomy: A nationwide questionnaire and database stud ', Anesthesiology, vol. 106, pp. 1003-1012 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::36a11722da2323bf8f6ca0d18bba5b1d
https://pure.au.dk/portal/en/publications/risk-factors-for-chronic-pain-after-hysterectomy-a-nationwide-questionnaire-and-database-stud(93025e70-fe01-11db-bee9-02004c4f4f50).html